MIT Jameel Clinic

MIT Jameel Clinic is an MIT-embedded research lab funded by Community Jameel as its primary philanthropic backer. The clinic was built to push AI into clinical diagnosis, drug discovery, and epidemiology, with faculty co-leads Regina Barzilay and Jim Collins guiding a program that sits inside MIT rather than outside it. This is not a public open-call program. Funding flows through MIT and other institutional channels, and the clinic has been supported alongside partners such as Wellcome, Sanofi, and the Islamic Development Bank. The record also ties it to major outputs, including antibiotics such as halicin and abaucin, prediction tools such as MIRAI and SYBIL, and an antimicrobial-resistance platform that received up to USD 27 million from ARPA-H in September 2024. The clinic’s reach is broad by research-lab standards, with a network of 65 hospitals across more than 14 countries as of 2024. For researchers, the relevant path is collaboration with MIT-side leadership and internal funding decisions, not a standalone external application to Community Jameel.

No upcoming rounds verified. Cadence: Rolling.